Anubis BioConsulting

Our Story: From Research Roots to Strategic Guidance

What began as a pursuit to understand the molecular foundations of disease has evolved into a mission to support the journey from discovery to commercialization through practical investment and operational guidance. With deep roots in biomedical research—spanning oncology, neuroscience, immunology, and life sciences investments—we understand the challenges of turning innovations into market-ready solutions.

Informed Decisions in Biotech

We guide life sciences investors through complex landscapes with rigorous analysis and strategic insights. Our technical due diligence helps navigate market volatility, emerging technologies, and regulatory requirements, enabling confident investments.

• Competitive Intelligence: Map market players and opportunities to identify high-potential ventures.

• Market Analysis: Evaluate trends, sizing, and dynamics for commercial viability.

• Regulatory Compliance & IP Review: Assess patents, freedom to operate, and global compliance to minimize risks.

• Expert & KOL Network: Connect with industry leaders for authoritative insights and validation.

• Regulatory Navigation: Develop approval pathways and risk mitigation strategies.

• Technology Assessment: Analyze scientific viability, feasibility, and scalability for true investment value.

By integrating scientific expertise into your due diligence, risk assessment, and market analysis, we deliver actionable recommendations that support long-term success and valuable connections with funding-ready startups.

Building Paths to Success

We partner with life sciences startups to develop tailored strategies for funding, regulatory compliance, and commercialization. Our biotech consulting helps you optimize resources, mitigate risks, and accelerate progress in a competitive landscape.

• Strategic Planning & Development: Guide product development from concept to market with roadmaps, mission/vision alignment, go-to-market analysis, and strategy reassessments.

• Project Management & Execution: Provide study oversight, KPIs, and balanced scorecards to keep initiatives on track.

• Clinical & Regulatory Advancement: Navigate clinical trials, regulatory pathways (including IBC, IRB, and IACUC assistance), preclinical testing, and scientific validation for FDA-ready evidence.

• Funding & Investment: Craft grant proposals, SBIR/STTR support, investment strategies, fundraising materials (e.g., pitch decks), budgeting, and tax reporting to secure resources and structure rounds.

• Intellectual Property & Protection: Develop IP portfolios and protection strategies to maximize value.

• Communication & Partnerships: Create pitches, handle negotiations, and build expert networks for strong collaborations.

We combine industry best practices with your unique goals to create clear launch pathways, professional funding materials, and efficient processes that lead to measurable impact.

Our Investment Focus: Driving Value in Life Sciences

• Due Diligence: Leverage over a decade of research experience to assess scientific validity, competitive positioning, and regulatory pathways.

• Market Entry Strategy: Guide companies through U.S. healthcare dynamics and partnership development.

• Value Creation: Identify inflection points that boost valuation and craft fundraising strategies aligned with investor expectations and market timing.

Ready to Connect?

Whether you're a startup seeking funding strategies or an investor looking for thorough due diligence, we're here to help. Contact us today for a free consultation.

In the pipeline:

• European Growth: Supporting an EU-based startup hub with fundraising strategies, product roadmap development, and navigating regulations

• Diagnostic devices: Supporting a US-based big data startup to optimize and launch an early-stage cancer detection system

"Anubis BioConsulting was instrumental in developing my report on the role of stakeholders in corporate sustainability"

Roberta Zizzari, Attorney

"This is a much better pitch! Well done! I'm excited to see how this might shift the conversations..."

Founder and branding specialist

Member of the Bullpen Club since 2025